Susquehanna International Group
AXDX

Susquehanna International Group’s Accelerate Diagnostics AXDX Stock Holding History

Susquehanna International Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,050
Closed -$92.7K – 12544
2022
Q4 		$92.7K Sell
13,050
-24,710
-65% -$270K ﹤0.01% 11021
2022
Q3 		$574K Buy
37,760
+24,150
+177% +$400K ﹤0.01% 8119
2022
Q2 		$135K Buy
13,610
+490
+4% +$4.33K ﹤0.01% 11149
2022
Q1 		$189K Sell
13,120
-2,270
-15% -$64.6K ﹤0.01% 11300
2021
Q4 		$803K Buy
15,390
+2,420
+19% +$135K ﹤0.01% 7870
2021
Q3 		$756K Sell
12,970
-790
-6% -$51.5K ﹤0.01% 8288
2021
Q2 		$1.11M Sell
13,760
-1,180
-8% -$93.8K ﹤0.01% 7481
2021
Q1 		$1.24M Buy
14,940
+5,540
+59% +$562K ﹤0.01% 7144
2020
Q4 		$713K Sell
9,400
-1,420
-13% -$127K ﹤0.01% 7502
2020
Q3 		$1.15M Sell
10,820
-10,730
-50% -$1.49M ﹤0.01% 5758
2020
Q2 		$3.27M Buy
21,550
+5,270
+32% +$520K ﹤0.01% 3652
2020
Q1 		$1.36M Sell
16,280
-16,250
-50% -$2.29M ﹤0.01% 4698
2019
Q4 		$5.5M Buy
32,530
+5,130
+19% +$847K ﹤0.01% 2853
2019
Q3 		$5.09M Buy
27,400
+6,520
+31% +$1.26M ﹤0.01% 2706
2019
Q2 		$4.78M Buy
20,880
+15,560
+292% +$3.04M ﹤0.01% 2772
2019
Q1 		$1.12M Sell
5,320
-23,600
-82% -$4.42M ﹤0.01% 4829
2018
Q4 		$3.33M Buy
28,920
+4,640
+19% +$687K ﹤0.01% 2792
2018
Q3 		$5.57M Buy
24,280
+1,790
+8% +$396K ﹤0.01% 2551
2018
Q2 		$5.01M Buy
22,490
+2,200
+11% +$492K ﹤0.01% 2702
2018
Q1 		$4.64M Buy
20,290
+4,660
+30% +$1.22M ﹤0.01% 2635
2017
Q4 		$4.09M Sell
15,630
-9,400
-38% -$2.2M ﹤0.01% 2791
2017
Q3 		$5.62M Buy
25,030
+4,410
+21% +$1.08M ﹤0.01% 2358
2017
Q2 		$5.64M Buy
20,620
+6,530
+46% +$1.77M ﹤0.01% 2265
2017
Q1 		$3.41M Buy
14,090
+1,520
+12% +$347K ﹤0.01% 2840
2016
Q4 		$2.61M Buy
12,570
+1,710
+16% +$406K ﹤0.01% 3510
2016
Q3 		$2.96M Buy
10,860
+4,100
+61% +$907K ﹤0.01% 2923
2016
Q2 		$973K Buy
6,760
+2,810
+71% +$377K ﹤0.01% 4933
2016
Q1 		$568K Sell
3,950
-440
-10% -$62.1K ﹤0.01% 6180
2015
Q4 		$943K Sell
4,390
-100
-2% -$18.3K ﹤0.01% 5528
2015
Q3 		$726K Buy
4,490
+2,470
+122% +$534K ﹤0.01% 6387
2015
Q2 		$533K Sell
2,020
-7,200
-78% -$1.72M ﹤0.01% 7516
2015
Q1 		$2.08M Buy
9,220
+5,660
+159% +$1.18M ﹤0.01% 4256
2014
Q4 		$683K Sell
3,560
-2,110
-37% -$452K ﹤0.01% 6620
2014
Q3 		$1.22M Sell
5,670
-5,600
-50% -$1.09M ﹤0.01% 5560
2014
Q2 		$2.93M Buy
11,270
+7,690
+215% +$1.68M ﹤0.01% 3962
2014
Q1 		$781K Buy
3,580
+2,000
+127% +$296K ﹤0.01% 5962
2013
Q4 		$193K Buy
+1,580
New +$211K ﹤0.01% 8300

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Susquehanna International Group's AXDX Position: Q2 2025 in Review

Susquehanna International Group sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 55,268 shares — an estimated $38.7K sold.

Susquehanna International Group first reported a position in AXDX in Q4 2013 and held it in 37 quarters. The position peaked at $10.8M in Q3 2018. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Susquehanna International Group reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 55,268 Accelerate Diagnostics shares in Q2 2025, an estimated $38.7K.
  • Susquehanna International Group first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 37 quarters.
  • Susquehanna International Group's Accelerate Diagnostics position peaked at $10.8M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.